Inland Revenue Board (IRB) warns against fake e-mail, SMS offering BR1M insurance service

By Editorial Team -
PETALING JAYA: The Inland Revenue Board (IRB) has warned the public against e-mail or SMS offering a 1Malaysia People’s Aid (BR1M) insurance service, saying it has not issued any such messages. 
In a statement on Friday, the board noted that there had been numerous enquiries from people who had allegedly received such messages offering a BR1M insurance service called i-BR1M 
“IRB confirms that we have neither issued any e-mail nor SMS through any officer to any applicant or recipient,” read the statement. 
The statement also asked for all those who have received the e-mail or sms to delete it and not provide the sender any feedback. 
Public who would require further clarification can either visit the official BR1M website at https://ebr1m.hasil.gov.my or call 1-800-88-2716.
http://www.thestar.com.my/News/Nation/2014/10/17/IRB-BR1M-insurance-service/

You may also wish to read:
How to reply to scammers?

Comments

Post a Comment

Pages

Popular posts from this blog

AI Crypto Trading Competition 2025: DeepSeek and Qwen-3 Dominate as Gemini and GPT-5 Suffer Major Losses

By -
Image
In this Article: AI models like DeepSeek, and Qwen-3 are up big in a live, real-money crypto trading showdown. GPT 5 is the biggest loser of the bunch, underscoring reliability and transparency risks. The results deepen the divide between data-specialized and general-purpose AI approaches to finance. In early innings, DeepSeek and Qwen3 are emerging as the top performers in a real-money AI crypto trading showdown, each generating returns of over 30% so far while rival models have suffered heavy losses. The " Alpha Arena ," a competition that pits prominent large language models against each other in the live cryptocurrency market, saw OpenAI's GPT-5 with staggering losses of more than 70% during the same period. ( decrypt.co ) In Alpha Arena, launched by US research firm Nof1, six large language models (LLMs) were given US$10,000 each to invest in six cryptocurrency perpetual contracts on the decentralised exchange Hyperliquid, including bitcoin and solana. The other LLMs...
Read more

Top 10 Pharmaceutical Companies by Revenue and Market Cap in 2025 (October Edition)

By -
Image
The pharmaceutical industry continues to show robust performance in Q3 2025, with key players reporting strong sales driven by oncology, immunology, and metabolic drugs. Eli Lilly maintains its lead in market capitalization, fueled by high demand for its GLP-1 treatments Mounjaro and Zepbound, with projected full-year revenue growth of around 32%. Johnson & Johnson reported Q3 sales of $24.0 billion, up 6.8%, and raised its 2025 sales outlook. Roche achieved 7% sales growth in the first nine months to CHF 45.9 billion ($52.8 billion), raising its full-year guidance to mid-single-digit growth. Other top companies like AstraZeneca, Novartis, and Vertex reported double-digit growth in key segments. Challenges persist, including patent expirations and biosimilar competition, but new approvals and acquisitions signal continued innovation. This edition updates data with Q3 2025 figures where available. Credit:  fiercepharma.co...
Read more

Top 10 Stock Picks for November 2025: Best Stocks to Buy Now for Growth Amid AI Boom, Tariff Concerns, and Fed Rate Cuts

By -
Image
Introduction The stock market in November 2025 continues to navigate a complex landscape shaped by President Trump's tariff policies, which have dialed back slightly but still contribute to persistent inflation around 3.5% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.75% so far this year—have fueled a market melt-up, with the S&P 500 rallying 36% over the past six months on strong corporate earnings and AI optimism. Gold prices have surged past $4,000 an ounce as a hedge, while cryptocurrencies hit new highs. However, warnings of an AI bubble abound, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy. Drawing from analyses by Zacks, Forbes, ValueSense, US News, and Morningstar, this list highlights 10 high-conviction picks emphasizing AI-driven growth, resilient sectors, and undervalued opportunities for diversification in a bifurcated economy. Top ...
Read more

Top 10 Stocks and ETFs Poised to Outperform in November 2025

By -
Image
As November 2025 unfolds, the stock market navigates a complex and evolving landscape shaped by President Trump's adjusted tariff policies, which have moderated slightly but still contribute to persistent inflation around 3.4% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.875% so far this year—have ignited a powerful market melt-up, with the S&P 500 rallying 39% over the past six months on strong corporate earnings and AI optimism. Gold prices have surged past $4,150 an ounce as a hedge and inflation buffer, while cryptocurrencies continue to hit new highs and maintain their upward trajectory. However, warnings of an AI bubble abound and linger, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy or if policies change. Drawing from analyses by Zacks, Forbes, ValueSense, US News, Morningstar, Bankrate, and Motley Fool, this list highlights 10 high-conv...
Read more

Top 10 Pharma Companies by Market Cap in 2025

By -
Image
Here are the top 10 pharmaceutical companies by market cap. The pharmaceutical industry remains robust amid evolving market dynamics, driven by innovation, strategic expansions, and shifting healthcare policies. This 2025 update integrates the first half's (H1) financial results to provide readers with a clear snapshot of leading companies’ performance and trajectory. In contrast, most of the other top 10 pharmaceutical companies are expected to see more moderate revenue growth, generally in the range of 6% to 9% by the end of 2025. This reflects steady but less dramatic expansion compared to Eli Lilly’s exceptional performance ( 4 ). Source: CompaniesMarketCap.com Lilly—boosted by sales of its diabetes and obesity drugs Moujaro and Zepbound— projects  its sales to fall between $58 billion and $61 billion. Meanwhile, Novo—which also has been powered by sales...
Read more

Top 10 ETF Picks for November 2025: Best Investments for Growth Amid AI Surge, Tariff Adjustments, and Ongoing Fed Easing

By -
Image
Introduction As November 2025 progresses, the stock market contends with an evolving backdrop marked by President Trump's adjusted tariff policies, which have moderated but sustain inflationary pressures near 3.3%. The Federal Reserve's total 1.00% rate cuts this year have ignited a powerful rally, driving the S&P 500 up 42% over the past six months, fueled by stellar earnings and AI progress. Gold has surpassed $4,300 per ounce as an inflation buffer, while cryptocurrencies maintain their upward trajectory. However, AI bubble worries linger, with lofty tech valuations susceptible to shifts if policies change. Aggregated from insights by Zacks, Forbes, Morningstar, Bankrate, and Motley Fool, this list spotlights 10 premier ETFs emphasizing AI innovation, sturdy sectors, and diversified strategies to traverse economic divides. Top 10 ETFs Selections highlight YTD performance, AUM for dependability, and anticipated growth in AI, tech, healthcare, and broad markets. Data sourc...
Read more

Top 10 Gold and Silver ETF Picks for November 2025: Best Investments for Hedging Amid Inflation, Tariff Adjustments, and Fed Easing

By -
Image
Introduction As November 2025 unfolds, the stock market navigates a complex and evolving landscape shaped by President Trump's adjusted tariff policies, which have moderated slightly but still contribute to persistent inflation around 3.4% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.875% so far this year—have ignited a powerful market melt-up, with the S&P 500 rallying 39% over the past six months on strong corporate earnings and AI optimism.  Gold prices have surged past $4,150 an ounce as a hedge and inflation buffer, while cryptocurrencies continue to hit new highs and maintain their upward trajectory. However, warnings of an AI bubble abound and linger, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy or if policies change. Silver prices have risen above $55 per ounce, fueled by industrial demand in solar and electronics. Drawing from analyse...
Read more

Top Gold ETFs to Watch in 2025: Best Picks for Strong Returns and Low Costs

By -
Image
Top gold ETFs to watch in 2025 span U.S., Indian, Europe and Chinese markets, offering both physical gold exposure and mining stock leverage. Based on the latest performance, expense ratios, and trends, key ETFs include: SPDR Gold Shares (GLD) : The largest gold ETF with $104.39 B in assets and 28 % year-to-date gain (as of September 2025). It remains a core holding for physical gold exposure globally ( 1 ,  10 ). SPDR Gold MiniShares Trust (GLDM) : One-year return in 2025, up around 41%, with a very low expense ratio (0.10%). It tracks physical gold closely and is highly liquid, making it a top choice for cost-conscious investors seeking strong recent gains ( 2 ,  1 ). iShares Gold Trust (IAU) 1-Year Return: 40 - 45% (reported range for 2025) ( TradingView ) YTD Performance: 35 - 40% (reported range for 2025) ( TradingView ) AUM:...
Read more

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights

By -
Image
As the cryptocurrency market matures in 2025, XRP ETFs have emerged as essential instruments for investors seeking regulated and accessible exposure to this dynamic digital asset. With a growing variety of futures-based and physically backed spot ETFs now available across major markets like the U.S., Canada, and Europe, understanding the nuances of these products—including their fee structures, holdings, and performance—is crucial for making informed investment decisions. This article highlights the top XRP ETFs to watch in 2025, providing deep insights into their dominating holdings, low fees, and recent market impact, all organized in a clear list format for easy navigation. Whether you are a long-term investor or an active trader, this guide will help you identify opportunities and risks in the evolving XRP ETF landscape. Update:  Top Bitcoin, Ethereum, and XRP ETFs to Watch in October 2025 : Updated Performance, AUM, and Investment Insights 1. Leading XRP ETFs in 2025 ProSha...
Read more

AI Demand Drives SSD & Memory Shortages: Prices Set to Rise for a Decade (2025)

By -
Image
Nearly every analyst firm and memory maker is now warning of looming NAND and DRAM shortages that will send SSD and memory prices skyrocketing over the coming months and years, with some even predicting a shortage that will last a decade. The shortages are becoming impossible to ignore, and warnings from the industry are growing dire, as the voracious appetite of AI data centers begins to consume the lion's share of the world's memory and flash production capacity. For the better part of two years, storage upgrades have been a rare bright spot for PC builders. SSD prices cratered to all-time lows in 2023 , with high-performance NVMe drives selling for little more than the cost of a modest mechanical hard disk. DRAM followed a similar trajectory, dropping to price points not seen in nearly a decade. In 2024, the pendulum swung firmly in the other direction, with prices for both NAND flash and DRAM starting to climb. The shift has its roots in the cyclical na...
Read more